Aptorum group Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Aptorum group Contact Number

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group is pursuing therapeutic projects in orphan diseases, infectious diseases, metabolic diseases, woman’s health and other disease areas.

Contact US: https://www.aptorumgroup.com/contact

Aptorum

26 People Used

See More ››

Aptorum Group Limited (APM) Pharmaceutical Company

For more information on Aptorum Group Limited, contact RedChip specialists at: 1-800-REDCHIP (733-2447) Company Overview Aptorum Group Limited (NASDAQ: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs.

View Contact ››

Diseases

31 People Used

See More ››

Aptorum Group

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group is pursuing therapeutic projects in orphan diseases, infectious diseases, metabolic diseases, woman’s health and other disease areas.

View Contact ››

Diseases

57 People Used

See More ››

Aptorum Group

Phone Number +44 20 80929299. Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to the discovery, development and commercializing of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers (including orphan oncology indications).

View Contact ››

Executive

111 People Used

See More ››

Aptorum Group CEO Subscribed Shares In The Company

NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--May 26, 2021-- Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced that Mr. Ian Huen, Founder, Chief Executive Officer and Executive …

View Contact ››

Aptorum

29 People Used

See More ››

Aptorum Group Limited (APM) Pharmaceutical Company

For more information on Aptorum Group Limited, contact RedChip specialists at: 1-800-REDCHIP (733-2447) Company Overview Aptorum Group Limited (NASDAQ: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs.

View Contact ››

Business

51 People Used

See More ››

Aptorum Group Limited (APM) Company Profile & Facts

See the company profile for Aptorum Group Limited (APM) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

View Contact ››

Investor

54 People Used

See More ››

Aptorum Group Limited To Present At The Benzinga Global

Aptorum Group Limited Investor Relations Department: [email protected] +44 20 80929299 Redchip – Financial Communications United States Investor relations Dave Gentry [email protected] +1 407 491 4498 Actifin – Financial Communications Europe Investor relations Ghislaine Gasparetto [email protected] +33 1 56 88 …

View Contact ››

Company

57 People Used

See More ››

Aptorum Group Ltd

Company profile page for Aptorum Group Ltd including stock price, company news, press releases, executives, board members, and contact information

View Contact ››

Investor

117 People Used

See More ››

Aptorum Group CEO Subscribed Shares In The Company

Contacts. Aptorum Group Limited Investor Relations Department: [email protected] +44 20 80929299 Redchip – Financial Communications United States Investor relations Dave Gentry

View Contact ››

Medical

58 People Used

See More ››

Aptorum Group CEO Subscribed Shares In The Company

NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--#biopharmaceutical--Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced that Mr. Ian Huen, Founder, Chief

View Contact ››

Please leave your comments here:

Popular Brands

Amazon
Asml
Abbvie
Apple
Att
Acc
Amd
Abb
Aak
Agco